Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 2 Interventional

A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes

ClinicalTrials.gov ID: NCT07890376

Public ClinicalTrials.gov record NCT07890376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY4086940 Compared With Placebo in Adult Participants With Obesity or Overweight and Without Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study, performed under the master protocol W8M-MC- CWMM (NCT06143956), is to evaluate the efficacy and safety of LY4086940 compared with placebo in participants without type 2 diabetes who have obesity or who have overweight with a weight-related health condition. Participation in the study will last about 58 weeks.

Study identification

NCT ID
NCT07890376
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
460 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2026 (Estimated)
Primary completion
Jan 2028 (Estimated)
Completion
Jun 2028 (Estimated)
Last update posted
Oct 22, 2026

2026 – 2028

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
38
Facility City State ZIP Site status
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa Chandler Arizona 85225 —
Headlands Research - Scottsdale Scottsdale Arizona 85260 —
The Institute for Liver Health II dba Arizona Liver Health-Tucson Tucson Arizona 85712 —
NorCal Medical Research, Inc Greenbrae California 94904 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Peninsula Research Associates Rolling Hills Estates California 90274 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Stamford Therapeutics Consortium Stamford Connecticut 06905 —
New Horizon Research Center Miami Florida 33165 —
Indago Research & Health Center, Inc Miami Lakes Florida 33016 —
Suncoast Clinical Research, Inc. New Port Richey Florida 34652 —
Charter Research - Winter Park Orlando Florida 32803 —
Charter Research - Lady Lake The Villages Florida 32162 —
Medical Research Partners Ammon Idaho 83406 —
Great Lakes Clinical Trials - Ravenswood Chicago Illinois 60640 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50266 —
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 —
Knownwell Needham Massachusetts 02492 —
Lucida Clinical Trials New Bedford Massachusetts 02740 —
Headlands Research - Detroit Southfield Michigan 48034 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Headlands Llc Springfield Missouri 65807 —
Las Vegas Medical Research Las Vegas Nevada 89128 —
Dent Neurologic Institute Amherst New York 14226 —
Rochester Clinical Research, LLC Rochester New York 14609 —
Monroe Biomedical Research Monroe North Carolina 28112 —
Lucas Research, Inc Morehead City North Carolina 28557 —
Lucas Research, Inc. New Bern North Carolina 28562 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Quality Medical Research Nashville Tennessee 37211 —
IMA Clinical Research Austin Austin Texas 78745 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
FutureSearch Trials of Dallas Dallas Texas 75251 —
Endeavor Clinical Trials San Antonio Texas 78240 —
Texas Valley Clinical Research Weslaco Texas 78596 —
Sovah Clinical Research-River District Danville Virginia 24541 —
Central Washington Health Services Association d/b/a Confluence Health Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07890376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07890376 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →